Menarini Group: Clinical Trials

4 trials sponsored by Menarini Group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Menarini Group: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar
Tramadol Hydrochloride/Dexketoprofen Trometamol, Tramadol Hydrochloride/Paracetamol, Placebo - Acute Pain
Phase 4CompletedMenarini Group6542016-04-012021-03-24
Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients
Aclidinium/Formoterol, Placebo - Pulmonary Disease, Chronic Obstructive
Phase 4CompletedAstraZeneca2672015-04-272018-10-09
BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGH
Aclidinium Bromide, Placebo - Pulmonary Disease, Chronic Obstructive
Phase 4CompletedAstraZeneca3002015-03-012017-04-21
Effects of Nebivolol Versus Carvedilol on Cardiopulmonary Function at High Altitude in Healthy Subjects.
placebo, Carvedilol, Nebivolol - Hypoxia, Altitude
Phase 4CompletedIstituto Auxologico Italiano272006-05-012009-09-02

Conditions studied

Pulmonary Disease, Chronic Obstructive (2)  ·  Acute Pain (1)  ·  Heart Failure (1)  ·  Hypoxia (1)  ·  Motor Activity (1)  ·  Pain, Postoperative (1)

Interventions

aclidinium bromide (2)  ·  Acetaminophen (1)  ·  Carvedilol (1)  ·  Formoterol Fumarate (1)  ·  Nebivolol (1)  ·  Tramadol (1)  ·  dexketoprofen trometamol (1)

Countries

Hungary (3)  ·  Italy (3)  ·  Spain (3)  ·  Germany (2)  ·  United Kingdom (2)  ·  Canada (1)  ·  Poland (1)

Results publications

PMID 30782886, PMID 35342289

NIH funding

2014 (2)